Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CDIB Venture Capital Corporation is the private equity and venture capital arm of China Development Financial Holding Corporation, with a strong focus on healthcare investments. The firm manages over $2.5 billion USD in assets and has a dedicated strategy for high-potential startups in biotech, pharmaceuticals, med-tech, and digital health. With over 60 years of experience in PE/VC, it has invested in over 50 biotech companies globally, covering areas such as oncology, neurology, and ophthalmology through modalities like cell therapies, immunotherapies, and advanced drug delivery systems.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on CDIB Venture Capital Corporation.